Home | ANGLE plc
ANGLE Plc. Capture and harvest live, intact circulating tumor cells (CTCs) and CTC clusters from whole blood for downstream analysis..
Read Angleplc.com news digest here: view the latest ANGLE Plc articles and content updates right away or get to their most visited pages. Angleplc.com is not yet rated by Alexa and its traffic estimate is unavailable. It seems that ANGLE Plc content is notably popular in Canada. We haven’t detected security issues or inappropriate content on Angleplc.com and thus you can safely use it. Angleplc.com is hosted with Positive Infrastructure (United Kingdom) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
N/A
Visitors daily -
N/A
Pageviews daily -
N/A
Google PR -
N/A
Alexa rank
Best pages on Angleplc.com
-
ANGLE plc | Cells for Precision Medicine
ANGLE plc, providing translational researchers with the ability to capture and harvest circulating tumor cells and other rare cells of interest.
-
How the Parsortix System Works - ANGLE plc
Our Parsortix system uses a patented technology in the form of a disposable cassette to capture and then harvest circulating tumor cells (CTSs) from blood.
-
ANGLE plc's lead product is the Parsortix cell separation system which captures Circulating Tumor Cells (CTCs) from cancer patient blood.
Angleplc.com news digest
-
9 years
Video Interview 16 Feb 2015: Fully funded for Parsortix ovarian cancer care, new...
Andrew Newland, the chief executive of ANGLE plc (LON:AGL) spoke about the need for speed to progress the firm’s plans to revolutionise personalised cancer care for a slice of an £8bln market.
The post Video Interview 16 Feb 2015: Fully funded for Parsortix ovarian cancer care, new partnership with MD Anderson. appeared first on ANGLE plc.... -
9 years
Compatibility with cell-free DNA
Cancer Research UK Manchester Institute (formerly Paterson) have demonstrated the Parsortix system is compatible with the cell-free DNA approach by showing that the Parsortix system can work with the cells from the blood once the plasma has been removed...
-
10 years
Circulating Tumor Cell Extravasation
Non-blood cancers, for example breast, prostate, lung, and colorectal cancers, shed cancer cells into the bloodstream, in a process known as intravasation. These cancer cells are known as circulating tumor cells (CTCs).
The CTCs are important as they circulate in the bloodstream and can then escape the blood vessels to permeate other tissues and organs in a process known as extravasation to cause secondary cancers.... -
11 years
In Vitro Fertilisation (IVF) Single Embryo Transfer
NICE (the National Institute for Health and Clinical Excellence) have today published a draft guideline setting out a range of important developments in In vitro fertilisation (IVF) treatment entitled “Fertility: assessment and treatment for people with...
Domain history
| Web host: | Positive Infrastructure |
| Registrar: | 123-Reg Limited |
| Registrant: | Mick Velvick (MLM Services LLP) |
| Updated: | January 01, 2018 |
| Expires: | January 08, 2021 |
| Created: | January 08, 2004 |
Whois record
Safety scores
Trustworthiness
N/AChild safety
N/A
